tradingkey.logo

US FDA investigates death tied to Takeda's blood disorder drug

ReutersNov 21, 2025 4:42 PM

- The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' 4502.T blood disorder drug, the health regulator said on Friday.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI